Document is current
Any future updates will be listed below
-
Authors
Wagner, En-Young N.
Pichler, Eva Maria
Müller, Mario
Eisenhut, Andrea
Buadze, Ana
Xu, Yanhua
Seifritz, Erich
Strippoli, Marie-Pierre F.
Castelao, Enrique
Ranjbar, Setareh
Glaus, Jennifer
Vandeleur, Caroline
Preisig, Martin
von Känel, Roland
Ajdacic-Gross, Vladeta
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3200B0–105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401, 33CS30_177535 and 3247730_204523)
Faculty of Biology and Medicine of the University of Lausanne (Faculty of Biology and Medicine of the University of Lausanne)
GlaxoSmithKline (GlaxoSmithKline)
University of Zurich
- License Information
-
More Information
Article History
Received: 25 February 2024
Accepted: 30 September 2024
First Online: 16 October 2024
Declarations
:
: The CoLaus|PsyCoLaus study was approved by University of Lausanne’s Institutional Ethics Committee. All participants received a detailed description of the goals, procedures and funding of the study and signed a written informed consent form. All procedures involved in this report comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975 (2008 revision).
: The authors have no conflicts of interest to declare.
